Cargando…
Intravesical liposome drug delivery and IC/BPS
Intravesical therapy has previously shown to be effective in delaying or preventing recurrence of superficial bladder cancer. This local route of drug administration is now demonstrating promise in the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) with the benefit of minimal syst...
Autores principales: | Janicki, Joseph J., Gruber, Michele A., Chancellor, Michael B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708561/ https://www.ncbi.nlm.nih.gov/pubmed/26816855 http://dx.doi.org/10.3978/j.issn.2223-4683.2015.08.03 |
Ejemplares similares
-
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
por: Janicki, Joseph J., et al.
Publicado: (2016) -
Sexual pain and IC/BPS in women
por: Kim, Su Jin, et al.
Publicado: (2019) -
Biomarkers in the Light of the Etiopathology of IC/BPS
por: Neuhaus, Jochen, et al.
Publicado: (2021) -
Bladder Uptake of Liposomes after Intravesical Administration Occurs by Endocytosis
por: Rajaganapathy, Bharathi Raja, et al.
Publicado: (2015) -
Lectins as Biomarkers of IC/BPS Disease: A Comparative Study of Glycosylation Patterns in Human Pathologic Urothelium and IC/BPS Experimental Models
por: Peskar, Dominika, et al.
Publicado: (2022)